• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


158.0237 USD 0.00000.00%

As of 20:10:00 ET on 04/16/2014.

Snapshot for Merck KGaA (MKGAF)

Open: - Day's Range: - Volume: 250
Previous Close: 158.0237 52wk Range: 149.3065 - 181.0000 1-Yr Rtn: -

Stock Chart for MKGAF

No chart data available.
  • MKGAF:US 158.0237
  • 1D
  • 1M
  • 1Y
Interactive MKGAF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MKGAF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 12.5322
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 9.1260
Est. PEG Ratio 2.6450
Market Cap (M USD) 34,617.21
Shares Outstanding (M) 64.62
30 Day Average Volume 137
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.66%
Cash Dividend (EUR) 1.9000
Dividend Ex-Date 05/12/2014
5 Year Dividend Growth 2.06%
Next Earnings Announcement 05/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MKGAF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MKGAF

Merck KGaA is a global pharmaceutical and chemicals company. The Company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for flat screens and the pharmaceutical, food, cosmetics, packaging, and coatings.

Karl-Ludwig KleyChairman-Mgmt Board/CEOKai BeckmannChief Administration Officer
Stefan OschmannCEO:PharmaceuticalsBernd ReckmannCEO:Chemicals
More Company Profile & Key Executives for MKGAF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil